PATENT CLAIM ANALYSIS

Application Number: 15759674
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2019-02
Patent Classification: ["424", "465000"]

Abstract:
The present invention relates to novel pharmaceutical formulations which have controlled, delayed release of active ingredient, and to a process for the preparation of such formulations. The invention additionally relates to the use of these novel pharmaceutical administration forms as medicaments for the treatment of diseases which require delayed release of the active ingredient, such as hypertension, or asthmatic diseases.

Claim (Index 9):
Pharmaceutically active composition having extended release of active ingredient, prepared by a process according to  claim 1 , comprising the active ingredient propranolol and/or pharmaceutically tolerated salts, hydrates or solvates thereof as antihypertensive \u03b2-blocker and a co-mixture of microcrystalline celluloses and polyvinyl alcohols.

Metadata:
- Claim Count in Document: 52.0
- Percentile: 90.0
- Lexical Diversity: 1.73684
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12224385', '11202713', '14250785', '10630348', '10502648']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7163557926338866
- 35 USC 102 Novelty (BERT): 0.5028791443524889
- Combined Prediction Score: 0.695008127805747
- Mean Citation Score: 204.225754
- Max Citation Score: 248.98341
- Similarity Product: 168.85553416476844

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test